167 related articles for article (PubMed ID: 15341077)
1. [Antisense oligonucleotides: a new class of biologically active molecules].
Uteshev DB; Korostelev SA; Sergeev AV; Uteshev BS
Eksp Klin Farmakol; 2004; 67(3):76-9. PubMed ID: 15341077
[TBL] [Abstract][Full Text] [Related]
2. [Antisense oligonucleotides are clinically tested. They inhibit the expression of disease-related genes].
Sommer W; Heilig M
Lakartidningen; 1999 Jan; 96(4):348-54. PubMed ID: 10024826
[TBL] [Abstract][Full Text] [Related]
3. Antisense oligonucleotides strategy in the treatment of hypertension.
Kagiyama S; Kagiyama T; Phillips MI
Curr Opin Mol Ther; 2001 Jun; 3(3):258-64. PubMed ID: 11497350
[TBL] [Abstract][Full Text] [Related]
4. [Synthetic oligonucleotides and their application in gene therapy].
Iribarren AM
Medicina (B Aires); 1995; 55(3):263-6. PubMed ID: 8544726
[TBL] [Abstract][Full Text] [Related]
5. Antisense and RNA interference approaches to target validation in pain research.
Kurreck J
Curr Opin Drug Discov Devel; 2004 Mar; 7(2):179-87. PubMed ID: 15603251
[TBL] [Abstract][Full Text] [Related]
6. LNA-antisense rivals siRNA for gene silencing.
Jepsen JS; Wengel J
Curr Opin Drug Discov Devel; 2004 Mar; 7(2):188-94. PubMed ID: 15603252
[TBL] [Abstract][Full Text] [Related]
7. ISIS 301012 gene therapy for hypercholesterolemia: sense, antisense, or nonsense?
Ito MK
Ann Pharmacother; 2007 Oct; 41(10):1669-78. PubMed ID: 17848425
[TBL] [Abstract][Full Text] [Related]
8. Liposomal antisense oligonucleotides for cancer therapy.
Siwak DR; Tari AM; Lopez-Berestein G
Methods Enzymol; 2004; 387():241-53. PubMed ID: 15172168
[No Abstract] [Full Text] [Related]
9. Antisense oligonucleotides in the treatment of Duchenne muscular dystrophy: Where are we now?
Wilton SD; Fletcher S
Neuromuscul Disord; 2005 Jun; 15(6):399-402. PubMed ID: 15907285
[No Abstract] [Full Text] [Related]
10. Antisense therapeutics: a promise waiting to be fulfilled.
Phillips MI
Methods Mol Med; 2005; 106():3-10. PubMed ID: 15375309
[No Abstract] [Full Text] [Related]
11. Antisense therapy for cancer.
Gleave ME; Monia BP
Nat Rev Cancer; 2005 Jun; 5(6):468-79. PubMed ID: 15905854
[TBL] [Abstract][Full Text] [Related]
12. Antisense therapeutics.
Persidis A
Nat Biotechnol; 1999 Apr; 17(4):403-4. PubMed ID: 10207893
[No Abstract] [Full Text] [Related]
13. Combined transcriptional and translational targeting of EWS/FLI-1 in Ewing's sarcoma.
Mateo-Lozano S; Gokhale PC; Soldatenkov VA; Dritschilo A; Tirado OM; Notario V
Clin Cancer Res; 2006 Nov; 12(22):6781-90. PubMed ID: 17121899
[TBL] [Abstract][Full Text] [Related]
14. 128th ENMC International Workshop on 'Preclinical optimization and Phase I/II Clinical Trials Using Antisense Oligonucleotides in Duchenne Muscular Dystrophy' 22-24 October 2004, Naarden, The Netherlands.
Muntoni F; Bushby K; van Ommen G
Neuromuscul Disord; 2005 Jun; 15(6):450-7. PubMed ID: 15907292
[No Abstract] [Full Text] [Related]
15. Special feature: A survey of the recent patent literature on the delivery of genes and oligonucleotides.
Mrsny RJ
J Drug Target; 1999; 7(1):1-10. PubMed ID: 10614811
[No Abstract] [Full Text] [Related]
16. Antisense inhibition: oligonucleotides, ribozymes, and siRNAs.
Zhang YC; Taylor MM; Samson WK; Phillips MI
Methods Mol Med; 2005; 106():11-34. PubMed ID: 15375310
[No Abstract] [Full Text] [Related]
17. Antisense strategies for oncogene inactivation.
Stein CA; Benimetskaya L; Mani S
Semin Oncol; 2005 Dec; 32(6):563-72. PubMed ID: 16338422
[TBL] [Abstract][Full Text] [Related]
18. Antisense strategy in malignant brain tumours treatment.
Trojan LA; Pan Y; Szpechcinski A; Ly A; Kopinski P; Chyczewski L; Kasprzak H; Donald A; Trojan J
Rocz Akad Med Bialymst; 2004; 49 Suppl 1():94-7. PubMed ID: 15638387
[No Abstract] [Full Text] [Related]
19. Targeted therapy of human laryngeal squamous cell carcinoma in vitro by antisense oligonucleotides directed against telomerase reverse transcriptase mRNA.
Tao Z; Chen S; Wu Z; Xiao B; Liu J; Hou W
J Laryngol Otol; 2005 Feb; 119(2):92-6. PubMed ID: 15829059
[TBL] [Abstract][Full Text] [Related]
20. Antisense therapeutics for hypertension: targeting the renin-angiotensin system.
Phillips MI; Kimura B
Methods Mol Med; 2005; 106():51-68. PubMed ID: 15375312
[No Abstract] [Full Text] [Related]
[Next] [New Search]
